S&P 500   5,075.58 (+0.11%)
DOW   38,877.37 (-0.18%)
QQQ   437.45 (+0.50%)
AAPL   180.23 (-0.66%)
MSFT   408.04 (+0.08%)
META   485.86 (+0.38%)
GOOGL   136.83 (+0.33%)
AMZN   174.75 (+0.92%)
TSLA   200.30 (-0.86%)
NVDA   791.73 (+1.94%)
NIO   5.64 (+3.87%)
AMD   187.86 (+6.41%)
BABA   74.17 (-0.56%)
T   16.99 (+0.18%)
F   12.38 (+0.65%)
MU   89.48 (-0.26%)
CGC   3.33 (-0.89%)
GE   155.77 (+0.10%)
DIS   111.28 (+0.43%)
AMC   4.41 (-11.62%)
PFE   26.74 (-1.11%)
PYPL   60.10 (-0.25%)
XOM   104.72 (+0.38%)
S&P 500   5,075.58 (+0.11%)
DOW   38,877.37 (-0.18%)
QQQ   437.45 (+0.50%)
AAPL   180.23 (-0.66%)
MSFT   408.04 (+0.08%)
META   485.86 (+0.38%)
GOOGL   136.83 (+0.33%)
AMZN   174.75 (+0.92%)
TSLA   200.30 (-0.86%)
NVDA   791.73 (+1.94%)
NIO   5.64 (+3.87%)
AMD   187.86 (+6.41%)
BABA   74.17 (-0.56%)
T   16.99 (+0.18%)
F   12.38 (+0.65%)
MU   89.48 (-0.26%)
CGC   3.33 (-0.89%)
GE   155.77 (+0.10%)
DIS   111.28 (+0.43%)
AMC   4.41 (-11.62%)
PFE   26.74 (-1.11%)
PYPL   60.10 (-0.25%)
XOM   104.72 (+0.38%)
S&P 500   5,075.58 (+0.11%)
DOW   38,877.37 (-0.18%)
QQQ   437.45 (+0.50%)
AAPL   180.23 (-0.66%)
MSFT   408.04 (+0.08%)
META   485.86 (+0.38%)
GOOGL   136.83 (+0.33%)
AMZN   174.75 (+0.92%)
TSLA   200.30 (-0.86%)
NVDA   791.73 (+1.94%)
NIO   5.64 (+3.87%)
AMD   187.86 (+6.41%)
BABA   74.17 (-0.56%)
T   16.99 (+0.18%)
F   12.38 (+0.65%)
MU   89.48 (-0.26%)
CGC   3.33 (-0.89%)
GE   155.77 (+0.10%)
DIS   111.28 (+0.43%)
AMC   4.41 (-11.62%)
PFE   26.74 (-1.11%)
PYPL   60.10 (-0.25%)
XOM   104.72 (+0.38%)
S&P 500   5,075.58 (+0.11%)
DOW   38,877.37 (-0.18%)
QQQ   437.45 (+0.50%)
AAPL   180.23 (-0.66%)
MSFT   408.04 (+0.08%)
META   485.86 (+0.38%)
GOOGL   136.83 (+0.33%)
AMZN   174.75 (+0.92%)
TSLA   200.30 (-0.86%)
NVDA   791.73 (+1.94%)
NIO   5.64 (+3.87%)
AMD   187.86 (+6.41%)
BABA   74.17 (-0.56%)
T   16.99 (+0.18%)
F   12.38 (+0.65%)
MU   89.48 (-0.26%)
CGC   3.33 (-0.89%)
GE   155.77 (+0.10%)
DIS   111.28 (+0.43%)
AMC   4.41 (-11.62%)
PFE   26.74 (-1.11%)
PYPL   60.10 (-0.25%)
XOM   104.72 (+0.38%)
NYSE:LMND

Lemonade (LMND) Stock Price, News & Analysis

$16.52
+0.82 (+5.22%)
(As of 12:17 PM ET)
Today's Range
$15.61
$16.72
50-Day Range
$15.31
$21.74
52-Week Range
$10.27
$24.81
Volume
2.94 million shs
Average Volume
1.99 million shs
Market Capitalization
$1.16 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.71

Lemonade MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.50 Rating Score
Upside/​Downside
13.3% Downside
$13.71 Price Target
Short Interest
Bearish
31.19% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.76
Upright™ Environmental Score
News Sentiment
0.51mentions of Lemonade in the last 14 days
Based on 12 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($3.13) to ($2.63) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.67 out of 5 stars

Finance Sector

713th out of 873 stocks

Fire, Marine, & Casualty Insurance Industry

40th out of 51 stocks


LMND stock logo

About Lemonade Stock (NYSE:LMND)

Lemonade, Inc. provides various insurance products in the United States and Europe. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property. The company also offers renters, homeowners, car, pet, and life insurance products, as well as landlord insurance policies. In addition, it operates as an agent for other insurance companies. The company was formerly known as Lemonade Group, Inc. and changed its name to Lemonade, Inc. Lemonade, Inc. was incorporated in 2015 and is headquartered in New York, New York.

LMND Stock Price History

LMND Stock News Headlines

Why Lemonade Stock Turned Sour Today
Game-Changing Cancer Tech Nears FDA Completion
In the world of tech advancements, a new player could outshine even AI. It's a revolutionary technology with the aim of transforming cancer detection. Imagine the leap from basic reading glasses to cutting-edge VR; that's the scale of innovation we're talking about. FDA review is in its final stages and it could become the gold standard before we know it.
Why Is Lemonade Stock Plummeting Today?
Lemonade Target of Unusually High Options Trading (NYSE:LMND)
Lemonade (LMND) Set to Announce Quarterly Earnings on Tuesday
Game-Changing Cancer Tech Nears FDA Completion
In the world of tech advancements, a new player could outshine even AI. It's a revolutionary technology with the aim of transforming cancer detection. Imagine the leap from basic reading glasses to cutting-edge VR; that's the scale of innovation we're talking about. FDA review is in its final stages and it could become the gold standard before we know it.
Lemonade: Premiums Are Growing And Losses Are Slimming
When Life Gives You Lemonade, Book Your Tax Losses
Why Lemonade Is A Smart Long-Term Investment
Lemonade: Ignore Outliers, Focus On The Long Term
Lemonade Is Just Getting Started
Lemonade: Big Strides On All Fronts
Lemonade's 50% Growth Might Not Be Enough
Lemonade: The Big Q1 Beat
Lemonade: Solid Quarterly Results Set Up A Trade
Lemonade: The Bull Thesis Is Starting To Play Out
Why Is Lemonade (LMND) Stock in the Spotlight?
Why Lemonade Stock Looks Like a Buy Here
Insurtech Bet Lemonade Stock Is Low Enough to Buy Now
Lemonade is Having a Bit of an Identity Crisis
See More Headlines
Receive LMND Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lemonade and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Today
2/29/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Fire, marine, & casualty insurance
Sub-Industry
N/A
Fax
N/A
Employees
1,367
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$13.71
High Stock Price Target
$17.00
Low Stock Price Target
$9.00
Potential Upside/Downside
-15.4%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
6 Analysts

Profitability

Net Income
$-297,800,000.00
Pretax Margin
-64.14%

Debt

Sales & Book Value

Annual Sales
$402.70 million
Book Value
$12.53 per share

Miscellaneous

Free Float
61,743,000
Market Cap
$1.10 billion
Optionable
Optionable
Beta
1.92
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives















LMND Stock Analysis - Frequently Asked Questions

Should I buy or sell Lemonade stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Lemonade in the last twelve months. There are currently 3 sell ratings and 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" LMND shares.
View LMND analyst ratings
or view top-rated stocks.

What is Lemonade's stock price target for 2024?

6 brokerages have issued 12-month price targets for Lemonade's shares. Their LMND share price targets range from $9.00 to $17.00. On average, they predict the company's stock price to reach $13.71 in the next twelve months. This suggests that the stock has a possible downside of 13.3%.
View analysts price targets for LMND
or view top-rated stocks among Wall Street analysts.

How have LMND shares performed in 2024?

Lemonade's stock was trading at $16.13 at the start of the year. Since then, LMND shares have decreased by 2.0% and is now trading at $15.81.
View the best growth stocks for 2024 here
.

When is Lemonade's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our LMND earnings forecast
.

How were Lemonade's earnings last quarter?

Lemonade, Inc. (NYSE:LMND) announced its earnings results on Tuesday, February, 27th. The company reported ($0.61) earnings per share for the quarter, topping analysts' consensus estimates of ($0.79) by $0.18. The business earned $115.50 million during the quarter, compared to analyst estimates of $111.71 million. Lemonade had a negative trailing twelve-month return on equity of 30.64% and a negative net margin of 55.12%. Lemonade's revenue was up 30.7% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.93) EPS.

What guidance has Lemonade issued on next quarter's earnings?

Lemonade issued an update on its first quarter 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $111.0 million-$113.0 million, compared to the consensus revenue estimate of $119.8 million.

What is Daniel Schreiber's approval rating as Lemonade's CEO?

121 employees have rated Lemonade Chief Executive Officer Daniel Schreiber on Glassdoor.com. Daniel Schreiber has an approval rating of 99% among the company's employees. This puts Daniel Schreiber in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Lemonade own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lemonade investors own include NVIDIA (NVDA), Tesla (TSLA), Teladoc Health (TDOC), CrowdStrike (CRWD), Block (SQ), DocuSign (DOCU), PayPal (PYPL), Zoom Video Communications (ZM), Intel (INTC) and Datadog (DDOG).

When did Lemonade IPO?

(LMND) raised $270 million in an initial public offering on Thursday, July 2nd 2020. The company issued 11,000,000 shares at a price of $23.00-$26.00 per share. Goldman Sachs, Morgan Stanley, Allen & Company and Barclays Capital acted as the underwriters for the IPO and JMP Securities, Oppenheimer, William Blair and LionTree were co-managers.

Who are Lemonade's major shareholders?

Lemonade's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (7.43%), Baillie Gifford & Co. (6.51%), Citadel Advisors LLC (0.00%), Legal & General Group Plc (0.77%), Northern Trust Corp (0.71%) and Charles Schwab Investment Management Inc. (0.66%). Insiders that own company stock include Becker Caryn Seidman, John Sheldon Peters, Michael A Eisenberg and Timothy E Bixby.
View institutional ownership trends
.

How do I buy shares of Lemonade?

Shares of LMND stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:LMND) was last updated on 2/29/2024 by MarketBeat.com Staff